3 ANNEX III Criteria for sampling strategy for national risk-based control plan for production in the Member States (as referred to in Article 2(2)), Regulation (EU) 2022/1644

In forcesince 7 Jul 2022
1.

Sampling shall be carried out in variable intervals spread evenly over all months of the year or relevant production period. In this context, it shall be considered that a number of pharmacologically active substances are administered only in particular seasons.

2.

Sampling shall be performed at or close to slaughter, collection or harvest. However, for Group A substances sampling should also be performed at any relevant stage in the life cycle of the animals.

3.

All samples shall be targeted according to the criteria laid down in the national control plan. For Group A substances, sampling shall be targeted at detection of illegal treatment with prohibited or unauthorised substances – thus animals which are most likely to have been treated are preferentially selected over those animals which are not, and, as much of this sampling is carried out on farm, samples of drinking water and feed may be appropriate in addition to inedible materials such as blood, urine, faeces, hair etc.

4.

For Group B substances, samples shall comprise only edible tissues/products (the objective is to verify compliance with maximum residue limits and maximum levels). Sampling shall be targeted on products from those animals, which are most likely to have been treated with a specific pharmacologically active substance or substance within therapeutic class of veterinary medicinal products.

5.

Samples from injection sites can be appropriate to control the illegal use of substances. In case samples are taken from injection sites, this shall be clearly mentioned when reporting analytical results from these samples.

6.

Criteria for the selection of the animals or products to be controlled for each food business operator to be controlled:

history of non-compliance of the farm or producer;

shortcomings in the application of veterinary medicinal products, deficiencies identified in previous controls, reported increase of losses of animals on the farm, animal health status of the farm, epidemiological status of the region;

information on the farming system, fattening system, breed and sex of the animals;

common practices with regard to the administration of particular pharmacologically active substances in the respective farm or production system;

indications of the use of pharmacologically active substances;

the absence or the unreliability of own-checks, the membership of quality assurance schemes (when available) and results of testing under such schemes;

evidence of insufficient supervision of the farm by veterinarians;

representative sampling regardless the size of the food business operator.

7.

Criteria for the selection of slaughterhouses, cutting plants, establishments for the milk production, establishments for the production and placing on the market of aquaculture products, establishments for honey and egg and egg packing centres from which samples should be taken:

the criteria listed under points A.2 and B.1 of Annex II and point 6 of this Annex;

the respective establishments’ share of the country’s total production volume;

non-compliance identified in earlier controls on the use of pharmacologically active substances and residues thereof in animals and animal products;

origins and transport routes of the slaughtered animals, milk, eggs or honey;

absence of participation in quality assurance programmes (when available);

the scope and results of own-checks for residues.

8.

When taking the samples, efforts shall be made to avoid multiple sampling (i.e. the taking of several different samples from a single animal/product (unless the different samples are analysed for a different group of substances), or sampling several animals/products from a single producer on a given day when samples could be drawn from animals/products from several producers which would satisfy the targeting criteria) unless the operator has been identified on the basis of the criteria included in point 6 or an appropriate justification has been provided in the control plan. The compliance with the planned frequency of checks shall be ensured.